Abstract
International prostate symptom score (IPSS) was claimed to be complicated for patients. The aim of this study was to measure differences in IPSS when introduced by a physician vs self-administration. Patients with lower urinary tract symptoms completed two IPSS questionnaires: one self-administrated and the other by a physician 1 week apart. Results with 75 patients in each group suggested that there was no statistically significant difference between patient and physician administration, although the mean scores of patients’ administration were higher in both groups. In conclusion, when assessing IPSS before treatment, we found no difference between patient administration and physician administration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bruskewitz R . Management of symptomatic BPH in US: who is treated and how? Eur Urol 1999; 36: 7–13.
Roehrborn CG . The newly established guidelines for the diagnosis and management of benign prostatic hyperplasia. Curr Opin Urol 1995; 5: 30–35.
Mebust WK, Holtgrewe HL, Cockett ATK, Peter PC and Writing Committee . Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of thirteen participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243–253.
McConnell JD . Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan Jr ED and Wein AJ (eds). Campbell's Urology, 7th edn. WB Saunders Company: Philadelphia, PA, 1998, pp 1429–1452.
Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–1557.
Jepsen JV, Bruskewitz RC . Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998; 51 (4A Suppl): 13–18.
Jepsen JV, Bruskewitz RC . Office evaluation of men with lower urinary tract symptoms. Urol Clin North Am 1998; 25: 545–554.
Lujan Galan M et al. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch Esp Urol 1997; 50: 847–853.
MacDiarmid SA et al. An assessment of the comprehension of the American Urological Association Symptom Index. J Urol 1998; 159: 873–874.
Gee WF et al. 1997 American Urological Association Gallup Survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994–1997. J Urol 1998; 160: 1804–1807.
Netto Jr NR et al. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia. Urology 1997; 49: 46–49.
Russo F et al. International prostate symptom score: comparison of doctor and patient. Arch Ital Urol Androl 1998; 70: 15–24.
Cockett ATK . Editorial comment: symptom score in patients with benign prostatic hyperplasia. J Urol 1996; 155: 1959.
Cam K, Senel F, Akman Y, Erol A . The efficacy of an abbreviated model of International Prostate Symptom Score in evaluating benign prostatic hyperplasia. BJU Int 2003; 91: 186–189.
Plante M et al. The international prostate symptom score: physician versus self-administration in the quantification of symptomatology. Urology 1996; 47: 326–328.
Netto Jr NR, de Lima ML . The influence of patient education level on the international prostatic symptom score. J Urol 1995; 154: 97–99.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cam, K., Akman, Y., Cicekci, B. et al. Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self. Prostate Cancer Prostatic Dis 7, 41–44 (2004). https://doi.org/10.1038/sj.pcan.4500683
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500683
Keywords
This article is cited by
-
Making shared decisions with older men selecting treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH): a pilot randomized trial
Journal of Patient-Reported Outcomes (2022)
-
Visual Analogue Score for Urinary Symptoms—VASUS, validation of a visual scale for lower urinary tract symptoms (LUTS) in an African country
World Journal of Urology (2021)
-
Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS)
World Journal of Urology (2020)
-
Comparability of Interviewer-Administration Versus Self-Administration of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB) Health-Related Quality of Life Questionnaire in Pulmonary Tuberculosis Patients
Pulmonary Therapy (2016)
-
Symptom scores: Mumbo jumbo or meaningful measures?
Current Prostate Reports (2005)